PortfoliosLab logoPortfoliosLab logo
ARWR vs. CALM
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ARWR vs. CALM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Arrowhead Pharmaceuticals, Inc. (ARWR) and Cal-Maine Foods, Inc. (CALM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ARWR achieves a 23.51% return, which is significantly higher than CALM's -3.25% return. Over the past 10 years, ARWR has outperformed CALM with an annualized return of 31.09%, while CALM has yielded a comparatively lower 9.14% annualized return.


ARWR

1D
0.22%
1M
9.41%
YTD
23.51%
6M
18.84%
1Y
435.25%
3Y*
32.51%
5Y*
-1.42%
10Y*
31.09%

CALM

1D
-2.26%
1M
-1.35%
YTD
-3.25%
6M
-7.64%
1Y
-21.70%
3Y*
26.10%
5Y*
21.91%
10Y*
9.14%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ARWR vs. CALM - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ARWR
Arrowhead Pharmaceuticals, Inc.
23.51%253.14%-38.56%-24.56%-38.82%-13.59%20.97%410.71%237.50%137.42%
CALM
Cal-Maine Foods, Inc.
-3.25%-15.61%87.00%14.48%51.87%-1.38%-12.19%2.09%-3.90%0.62%

Correlation

The correlation between ARWR and CALM is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.09

Correlation (5Y)
Calculated over the trailing 5-year period

0.10

Correlation (10Y)
Calculated over the trailing 10-year period

0.11

Correlation (All Time)
Calculated using the full available price history since Jan 6, 1997

0.09

Fundamentals

Market Cap

ARWR:

$11.68B

CALM:

$3.60B

EPS

ARWR:

-$2.16

CALM:

$14.48

PS Ratio

ARWR:

18.39

CALM:

1.05

PB Ratio

ARWR:

19.50

CALM:

1.33

Total Revenue (TTM)

ARWR:

$622.01M

CALM:

$3.46B

Gross Profit (TTM)

ARWR:

$529.27M

CALM:

$1.17B

EBITDA (TTM)

ARWR:

-$168.38M

CALM:

$1.05B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ARWR vs. CALM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARWR
ARWR Risk / Return Rank: 9999
Overall Rank
ARWR Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
ARWR Sortino Ratio Rank: 9898
Sortino Ratio Rank
ARWR Omega Ratio Rank: 9797
Omega Ratio Rank
ARWR Calmar Ratio Rank: 9999
Calmar Ratio Rank
ARWR Martin Ratio Rank: 9999
Martin Ratio Rank

CALM
CALM Risk / Return Rank: 1717
Overall Rank
CALM Sharpe Ratio Rank: 1313
Sharpe Ratio Rank
CALM Sortino Ratio Rank: 1414
Sortino Ratio Rank
CALM Omega Ratio Rank: 1515
Omega Ratio Rank
CALM Calmar Ratio Rank: 2020
Calmar Ratio Rank
CALM Martin Ratio Rank: 2424
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARWR vs. CALM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Arrowhead Pharmaceuticals, Inc. (ARWR) and Cal-Maine Foods, Inc. (CALM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ARWRCALMDifference
Sharpe ratioReturn per unit of total volatility

+7.38

Sortino ratioReturn per unit of downside risk

+6.11

Omega ratioGain probability vs. loss probability

1.68

0.90

+0.78

Calmar ratioReturn relative to maximum drawdown

17.81

-0.59

+18.40

Martin ratioReturn relative to average drawdown

49.05

-0.89

+49.95

ARWR vs. CALM - Sharpe Ratio Comparison

The current ARWR Sharpe Ratio is 6.72, which is higher than the CALM Sharpe Ratio of -0.67. The chart below compares the historical Sharpe Ratios of ARWR and CALM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ARWR vs. CALM - Drawdown Comparison

The maximum ARWR drawdown since its inception was -99.24%, which is greater than CALM's maximum drawdown of -74.08%. Use the drawdown chart below to compare losses from any high point for ARWR and CALM.


Loading charts...

Drawdown Indicators


ARWRCALMDifference

Max Drawdown

Largest peak-to-trough decline

-99.24%

-74.08%

-25.16%

Max Drawdown (1Y)

Largest decline over 1 year

-24.64%

-37.00%

+12.36%

Max Drawdown (3Y)

Largest decline over 3 years

-74.70%

-37.00%

-37.70%

Max Drawdown (5Y)

Largest decline over 5 years

-88.94%

-37.00%

-51.94%

Max Drawdown (10Y)

Largest decline over 10 years

-88.96%

-39.12%

-49.84%

Current Drawdown

Current decline from peak

-49.54%

-33.05%

-16.49%

Average Drawdown

Average peak-to-trough decline

-81.19%

-30.31%

-50.88%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.93%

24.35%

-15.42%

Volatility

ARWR vs. CALM - Volatility Comparison

Arrowhead Pharmaceuticals, Inc. (ARWR) has a higher volatility of 14.13% compared to Cal-Maine Foods, Inc. (CALM) at 6.47%. This indicates that ARWR's price experiences larger fluctuations and is considered to be riskier than CALM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ARWRCALMDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.13%

6.47%

+7.66%

Volatility (6M)

Calculated over the trailing 6-month period

36.34%

20.34%

+16.00%

Volatility (1Y)

Calculated over the trailing 1-year period

65.46%

32.76%

+32.70%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

65.02%

32.64%

+32.38%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

74.19%

31.15%

+43.04%

Dividends

ARWR vs. CALM - Dividend Comparison

ARWR has not paid dividends to shareholders, while CALM's dividend yield for the trailing twelve months is around 6.32%.


PositionTTM20252024202320222021202020192018201720162015
ARWR
Arrowhead Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
CALM
Cal-Maine Foods, Inc.
6.32%10.90%2.82%7.51%3.17%0.09%0.00%0.98%1.03%0.00%2.70%4.10%

Financials

ARWR vs. CALM - Financials Comparison

This section allows you to compare key financial metrics between Arrowhead Pharmaceuticals, Inc. and Cal-Maine Foods, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B20222023202420252026
73.74M
666.95M
(ARWR) Total Revenue
(CALM) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ARWR and CALM have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ARWR has higher volatility (14.13%) compared to CALM (6.47%). In terms of maximum drawdown, ARWR dropped -99.24% vs CALM's -74.08%.

ARWR currently has the higher Sharpe Ratio (6.72 vs -0.67), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ARWR and CALM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer